IFNA1 and breast carcinoma: Activation of innate and adaptive immune cells was seen in mice chimeric for these IFN-α-expressing macrophages and disease progression was inhibited in mouse and humanized mouse models of breast cancer with no evident signs of toxicity (53–55).